SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is experiencing significant upward momentum as its Amtagvi therapy demonstrates "remarkable" revenue growth and pipeline progress, pushing the stock past key technical levels and intensifying community speculation about a massive short squeeze.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is sharply higher as escalating Middle East tensions and concerns over the Strait of Hormuz disrupt global supply, driving crude oil prices to multi-year highs. The community is actively debating the sustainability of this rally and the potential for policy interventions to curb the price surge.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is surging after reporting strong Q4 earnings and issuing robust guidance, projecting accelerating data center and AI-driven revenue growth, which has led to numerous analyst upgrades. The community is buzzing about Marvell's pivotal role in AI infrastructure, from hyperscaler custom chips to optical connectivity, and the potential for S&P 500 inclusion.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is experiencing extreme volatility and divided opinion amid escalating Middle East tensions, including Strait of Hormuz disruptions and Qatar's LNG production halt, with bulls forecasting massive price spikes while bears highlight ample US supply and export limitations.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending as crude oil prices near $90 a barrel amid escalating Middle East tensions and warnings of potential $100-$150 oil. The community anticipates a significant short squeeze due to high short interest and a low float, drawing comparisons to its past explosive runs during similar geopolitical events, though some express frustration it hasn't "flown" like other oil stocks yet.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid intense community discussion linking recent geopolitical actions, particularly in Iran, to rising oil prices and broader economic instability. These concerns are frequently attributed to the current administration's policies, with recent insider share sales also fueling bearish sentiment around the stock.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as surging oil prices, fueled by escalating geopolitical tensions, and disappointing jobs data are creating significant market jitters. The community is sharply divided, with many anticipating further downside and urging caution heading into the weekend, while some opportunistic buyers eye dips.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following strong earnings and significantly raised long-term guidance for its AI chip revenue, fueled by new partnerships with major AI players, leading the community to discuss its impressive strength as a semiconductor giant in a challenging market.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as heightened geopolitical tensions amplify the focus on defense drone technology, with the community actively discussing potential large government contracts and recent collaborations for counter-drone innovations. Strong bullish sentiment is fueled by speculation around "Drone Dominance" initiatives and the company's Black Widow and maritime drone platforms.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending due to its announced acquisition by Servier for $21.50 per share, representing a significant premium that has delighted long-term holders and squeezed short sellers. The biotech sector is abuzz with the deal, highlighting successful M&A activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...

Wall Street Zen Downgrades Kyverna Therapeutics (NASDAQ:KYTX) to Sell

Wall Street Zen lowered Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Average Rating of "Moderate Buy" by Analysts

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are covering the stock, Marketbeat.com reports...

Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Sunday...

Kyverna Therapeutics (NASDAQ:KYTX) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen cut Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Consensus Rating of "Moderate Buy" by Analysts

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the company...

Kyverna Therapeutics Stock Up 41% in a Month: Here's Why

KYTX's shares surge after positive phase II data showed its CAR T miv-cel delivered major mobility gains in stiff person syndrome.

Kyverna Therapeutics (NASDAQ:KYTX) Major Shareholder Biopartners Opportuni Westlake Buys 133,333 Shares

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) major shareholder Biopartners Opportuni Westlake purchased 133,333 shares of the firm's stock in a transaction dated Thursday, December...

Kyverna Therapeutics (NASDAQ:KYTX) Major Shareholder Biopartners Opportuni Westlake Purchases 133,333 Shares

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) major shareholder Biopartners Opportuni Westlake acquired 133,333 shares of Kyverna Therapeutics stock in a transaction that occurred on...

Beth Seidenberg Purchases 133,333 Shares of Kyverna Therapeutics (NASDAQ:KYTX) Stock

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) Director Beth Seidenberg purchased 133,333 shares of the firm's stock in a transaction on Thursday, December 18th. The stock was acquired at...

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

KYTX
Kyverna Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KYTX News

KYTXKyverna Therapeutics Inc.